Involvement of graft-derived interleukin-15 in islet allograft rejection in mice

Cytokine

Volumn 34, Issue 1-2, 2006, Pages 106-113

  Lewis, Eli C ^a   Weiler, Michal ^a   Tejman Yarden, Noa ^a   Ziv, Nadav ^a   Mazar, Julia ^a   Chaimovitz, Cidio ^a   Douvdevani, Amos ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Antisense oligodeoxyribonucleotides; Immunosuppression; Minor histocompatibility antigens

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY RNA; INTERLEUKIN 15; INTERLEUKIN 2;

ACUTE GRAFT REJECTION; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOPLASM; EVALUATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; MINOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; CYTOPLASM; DIABETES MELLITUS, TYPE 1; EPITHELIAL CELLS; GRAFT REJECTION; INTERLEUKIN-15; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; NIH 3T3 CELLS; OLIGONUCLEOTIDES, ANTISENSE; T-LYMPHOCYTES;

EID: 33744535921     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.04.005     Document Type: Article

References (50)

1. Melzi R., Piemonti L., Nano R., Clissi B., Calori G., Antonioli B., et al. Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release. Transplantation 78 (2004) 1564-1567
2. Waldmann T.A., and Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 17 (1999) 19-49
3. McInnes I.B., and Gracie J.A. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol 4 (2004) 392-397
4. Manfro R.C., Roy-Chaudhury P., Zheng X.X., Steiger J., Nickerson P.W., Li Y., et al. Interleukin-15 gene transcripts are present in rejecting islet allografts. Transplant Proc 29 (1997) 1077-1078
5. Tagaya Y., Bamford R.N., DeFilippis A.P., and Waldmann T.A. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4 (1996) 329-336
6. Weng N.P., Liu K., Catalfamo M., Li Y., and Henkart P.A. IL-15 is a growth factor and an activator of CD8 memory T cells. Ann N Y Acad Sci 975 (2002) 46-56
7. Lodolce J., Burkett P., Koka R., Boone D., Chien M., Chan F., et al. Interleukin-15 and the regulation of lymphoid homeostasis. Mol Immunol 39 (2002) 537-544
8. Zambricki E., Shigeoka A., Kishimoto H., Sprent J., Burakoff S., Carpenter C., et al. Signaling T-cell survival and death by IL-2 and IL-15. Am J Transplant 5 (2005) 2623-2631
9. Ruckert R., Brandt K., Braun A., Hoymann H.G., Herz U., Budagian V., et al. Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo. J Immunol 174 (2005) 5507-5515
10. Muro S., Taha R., Tsicopoulos A., Olivenstein R., Tonnel A.B., Christodoulopoulos P., et al. Expression of IL-15 in inflammatory pulmonary diseases. J Allergy Clin Immunol 108 (2001) 970-975
11. Robak E., Robak T., Wozniacka A., Zak-Prelich M., Sysa-Jedrzejowska A., and Stepien H. Proinflammatory interferon-gamma-inducing monokines (interleukin-12, interleukin-18, interleukin-15)-serum profile in patients with systemic lupus erythematosus. Eur Cytokine Netw 13 (2002) 364-368
12. Liu Z., Geboes K., Colpaert S., D'Haens G.R., Rutgeerts P., and Ceuppens J.L. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J Immunol 164 (2000) 3608-3615
13. D'Auria L., Bonifati C., Cordiali-Fei P., Leone G., Picardo M., Pietravalle M., et al. Increased serum interleukin-15 levels in bullous skin diseases: correlation with disease intensity. Arch Dermatol Res 291 (1999) 354-356
14. Baan C.C., Niesters H.G., Metselaar H.J., Mol W.M., Loonen E.H., Zondervan P.E., et al. Increased intragraft IL-15 mRNA expression after liver transplantation. Clin Transplant 12 (1998) 212-218
15. Pavlakis M., Strehlau J., Lipman M., Shapiro M., Maslinski W., and Strom T.B. Intragraft IL-15 transcripts are increased in human renal allograft rejection. Transplantation 62 (1996) 543-545
16. McInnes I.B., Leung B.P., Sturrock R.D., Field M., and Liew F.Y. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med 3 (1997) 189-195
17. Liew F.Y., and McInnes I.B. Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis 61 Suppl 2:ii (2002) 100-102
18. Ruchatz H., Leung B.P., Wei X.Q., McInnes I.B., and Liew F.Y. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol 160 (1998) 5654-5660
19. Steiger J., Nickerson P.W., Steurer W., Moscovitch-Lopatin M., and Strom T.B. IL-2 knockout recipient mice reject islet cell allografts. J Immunol 155 (1995) 489-498
20. Li X.C., Roy-Chaudhury P., Hancock W.W., Manfro R., Zand M.S., Li Y., et al. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. J Immunol 161 (1998) 890-896
21. Vincenti F., Kirkman R., Light S., Bumgardner G., Pescovitz M., Halloran P., et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med 338 (1998) 161-165
22. Baan C.C., Knoop C.J., van Gelder T., Holweg C.T., Niesters H.G., Smeets T.J., et al. Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation. Transplantation 67 (1999) 870-876
23. Nashan B., Moore R., Amlot P., Schmidt A.G., Abeywickrama K., and Soulillou J.P. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet 350 (1997) 1193-1198
24. van Gelder T., Baan C.C., Balk A.H., Knoop C.J., Holweg C.T., van der Meer P., et al. Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humans. Transplantation 65 (1998) 405-410
25. Shi R., Yang J., Jaramillo A., Steward N.S., Aloush A., Trulock E.P., et al. Correlation between interleukin-15 and granzyme B expression and acute lung allograft rejection. Transpl Immunol 12 (2004) 103-108
26. Baan C.C., van Gelder T., Balk A.H., Knoop C.J., Holweg C.T., Maat L.P., et al. Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection. Transplantation 69 (2000) 331-336
27. Blaser B.W., Roychowdhury S., Kim D.J., Schwind N.R., Bhatt D., Yuan W., et al. Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease. Blood 105 (2005) 894-901
28. Smith X.G., Bolton E.M., and Bradley J.A. Targeting IL-15 as a therapeutic strategy in organ transplant rejection. Curr Opin Investig Drugs 3 (2002) 406-410
29. Ferrari-Lacraz S., Zheng X.X., Kim Y.S., Li Y., Maslinski W., Li X.C., et al. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection. J Immunol 167 (2001) 3478-3485
30. Zheng X.X., Sanchez-Fueyo A., Sho M., Domenig C., Sayegh M.H., and Strom T.B. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 19 (2003) 503-514
31. Zheng X.X., Gao W., Donskoy E., Neuberg M., Ruediger M., Strom T.B., et al. An antagonist mutant IL-15/Fc promotes transplant tolerance. Transplantation 81 (2006) 109-116
32. Smith X.G., Bolton E.M., Ruchatz H., Wei X., Liew F.Y., and Bradley J.A. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival. J Immunol 165 (2000) 3444-3450
33. Lewis E., Weiler M., Chaimovitz C., and Douvdevani A. Interleukin-15 is the main mediator of lymphocyte proliferation in cultures mixed with human kidney tubular epithelial cells. Transplantation 72 (2001) 886-890
34. Degiannis D., Kalteziotis V., Thalassinos A., Kapsalis A., Kroupis C., and Koniavitou K. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes. Transplant Proc 30 (1998) 948-949
35. Detrisac C.J., Sens M.A., Garvin A.J., Spicer S.S., and Sens D.A. Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 25 (1984) 383-390
36. Basok A., Shnaider A., Man L., Chaimovitz C., and Douvdevani A. CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES. J Am Soc Nephrol 12 (2001) 695-702
37. Weiler M., Rogashev B., Einbinder T., Hausmann M.J., Kaneti J., Chaimovitz C., et al. Interleukin-15, a leukocyte activator and growth factor, is produced by cortical tubular epithelial cells. J Am Soc Nephrol 9 (1998) 1194-1201
38. Salvalaggio P.R., Deng S., Ariyan C.E., Millet I., Zawalich W.S., Basadonna G.P., et al. Islet filtration: a simple and rapid new purification procedure that avoids ficoll and improves islet mass and function. Transplantation 74 (2002) 877-879
39. Kaiser P., Rothwell L., Vasicek D., and Hala K. A role for IL-15 in driving the onset of spontaneous autoimmune thyroiditis?. J Immunol 168 (2002) 4216-4220
40. Cardozo A.K., Proost P., Gysemans C., Chen M.C., Mathieu C., and Eizirik D.L. IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46 (2003) 255-266
41. Oppenheimer-Marks N., Brezinschek R.I., Mohamadzadeh M., Vita R., and Lipsky P.E. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest 101 (1998) 1261-1272
42. Kim Y.S., Maslinski W., Zheng X.X., Stevens A.C., Li X.C., Tesch G.H., et al. Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. J Immunol 160 (1998) 5742-5748
43. Baan C.C., van Riemsdijk-Overbeeke I.C., Boelaars-van Haperen M.J., JM I.J., and Weimar W. Inhibition of the IL-15 pathway in anti-CD25 mAb treated renal allograft recipients. Transpl Immunol 10 (2002) 81-87
44. Ferrari-Lacraz S., Zheng X.X., Kim Y.S., Maslinski W., and Strom T.B. Addition of an IL-15 mutant/FCgamma2A antagonist protein protects islet allografts from rejection overriding costimulation blockade. Transplant Proc 34 (2002) 745-747
45. Li X.C., Schachter A.D., Zand M.S., Li Y., Zheng X.X., Harmon W.E., et al. Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15. Transplantation 66 (1998) 265-268
46. Robertson H., and Kirby J.A. Post-transplant renal tubulitis: the recruitment, differentiation and persistence of intra-epithelial T cells. Am J Transplant 3 (2003) 3-10
47. Li X.C., Ima A., Li Y., Zheng X.X., Malek T.R., and Strom T.B. Blocking the common gamma-chain of cytokine receptors induces T cell apoptosis and long-term islet allograft survival. J Immunol 164 (2000) 1193-1199
48. Strehlau J., Pavlakis M., Lipman M., Maslinski W., Shapiro M., and Strom T.B. The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. Clin Nephrol 46 (1996) 30-33
49. Alileche A., Goldman C.K., and Waldmann T.A. Differential effects of IL-2 and IL-15 on expression of IL-2 receptor alpha. Biochem Biophys Res Commun 285 (2001) 1302-1308
50. Dubois S., Mariner J., Waldmann T.A., and Tagaya Y. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 17 (2002) 537-547